| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
Ticagrelor Impurity A
|
1788033-05-5 |
替格瑞洛杂质E
|
替卡格雷洛杂质14;替格瑞洛相关化合物41;TICAGRELOR-5;替格瑞洛杂质41;替卡格雷杂质E;替格瑞洛杂质E
|
C23H28F2N6O4S |
522.568026 | |
|
Palonosetron Impurity 15
|
177932-92-2 |
帕洛诺司琼杂质 7
|
Palonosetron Impurity 15
|
|||
|
(2R)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide
|
174756-44-6 |
沙芬酰胺对映异构体
|
沙芬酰胺杂质A;沙芬酰胺对映异构体;R-沙芬酰胺,即不含甲磺酸盐;沙芬酰胺杂质02;SAFINAMIDE-2
|
C17H19FN2O2 |
302.349 | |
|
Thioctic acid Impurity 4
|
17370-41-1 |
硫辛酸杂质F
|
硫辛酸杂质F;硫辛酸杂质1;硫辛酸杂质4;硫辛酸杂质 6
|
|||
|
Rosuvastatin Impurity 27
|
1714147-49-5 |
瑞舒伐他汀杂质
|
瑞舒伐他汀脱丙酮叉光降解-2
|
C29H42FN3O7S |
595.723083 | |
|
Posaconazole Impurity 17
|
171228-51-6 |
泊沙康唑杂质17
|
(3S,5S,2R,3S)-泊沙康唑;泊沙康唑杂质17
|
|||
|
Azilsartan Impurity 32
|
1696392-12-7 |
阿齐沙坦杂质
|
阿齐沙坦杂质 22;阿齐沙坦杂质32;AZILSARTAN-17
|
C29H25N3O7 |
||
|
Tofacitinib Impurity 11
|
1675248-19-7 |
托法替尼 杂质 K
|
TOFACITINIB-24;托法替尼相关化合物7;托法替尼杂质JJ;托法替尼 杂质 K;托法替尼杂质 10;托法替尼杂质25;托法替布酰胺杂质;DIC脲结构杂质
|
C16H22N6O2 |
330.38488 | |
|
Rivaroxaban Impurity 56
|
1643354-27-1 |
利伐沙班杂质61
|
Rivaroxaban impurity O: M1 + 2M2
|
|||
|
Empagliflozin Impurity 4
|
1620758-34-0 |
恩格列净杂质4
|
伊帕列净杂质;EMPAGLIFLOZIN-5;(1R)-1,5-二羟基恩格列净;依帕列净杂质4;恩格列净杂质05
|
C23H27ClO8 |
466.90868 | |
|
Empagliflozin α-Anomer
|
1620758-33-9 |
恩格列净杂质7
|
恩格列净杂质53;(R,S)-恩格列净杂质;EMPAGLIFLOZIN-1;恩格列净杂质07;恩格列净杂质01;恩格列净杂质异构体;恩格列净Α-异构体;恩格列净杂质001
|
C23H27ClO7 |
450.90928 | |
|
Ivabradine Impurity 2
|
1616710-50-9 |
伊伐布雷定杂质
|
伊伐布雷定杂质Y1021;伊伐布雷定杂质对照品;伊伐布雷定杂质;盐酸伊伐布雷定杂质;伊伐布雷定杂质12;3-(3-{[((7S)-3,4-二甲氧基双环[4.2.0]辛-1,3,5-三烯-7-基)甲基]甲基氨基}丙基)-1,4,5-四氢-7,8-二甲氧基-2H-3-苯并氮杂卓-1,2-二酮草酸盐;伊伐布雷定杂质15 HCL;3-(3-{[((7S)-3,2-二酮
|
C27H35ClN2O6 |
519.0296 | |
|
Ticagrelor Impurity F
|
1616703-93-5 |
替格瑞洛杂质F
|
替格瑞洛杂质F;替格瑞洛杂质F24;TICAGRELOR-6;替卡格雷洛杂质F
|
C25H30F2N6O5S |
564.604706 | |
|
Linezolid Impurity 33
|
1610690-08-8 |
利奈唑胺杂质
|
利奈唑胺杂质29
|
C13H18ClFN2O2 |
288.745623 | |
|
Irbesartan Hydroxy Impurity
|
160514-13-6 |
氯沙坦杂质B
|
氯沙坦杂质B;2'-(2H-四唑-5-基)-[1,1'-联苯]-4-甲醇;氯沙坦钾EP杂质B;缬沙坦杂质26;氯沙坦EP杂质B
|
C14H11N4O |
251.26334 | |
|
Losartan Hydroxy N2-Trityl Impurity
|
154709-18-9 |
奥美沙坦酯杂质S
|
OLMESARTAN MEDOXOMIL-10;奥美沙坦酯杂质S;奥美沙坦酯杂质S22;氯沙坦羟基N2-三苯甲基杂质;奥美沙坦酯杂质11;美沙坦酯杂质S
|
C33H26N4O |
494.58574 | |
|
Brinzolamide Related Compound C
|
154127-19-2 |
布林佐胺杂质A
|
布林佐胺杂质12;布林佐胺标准品6-S;布林佐胺杂质7;布林佐胺杂质A;(S)-4-(乙基氨基)-3,4-二氢-2-(3-甲氧基丙基)-2H-噻吩并[3,2-E]-1,2-噻嗪-6-磺酰胺 1,1-二氧化物;布林佐胺杂质A(USP标准);布林唑胺杂质A
|
C12H21N3O5S3 |
383.496 | |
|
Argatroban Impurity 4
|
153886-68-1 |
阿加曲班杂质G
|
阿加曲班杂质G;阿加曲班杂质4
|
C10H13NO3S |
227.28012 | -0 |
|
Febuxostat n-Propyl Ether Acid Impurity
|
1530308-87-2 |
非布索坦杂质U
|
FEBUXOSTAT-20;非布司他杂质16;非布司他杂质22;非布索坦杂质U;非布索坦杂质22;非布索坦杂质25;非布索坦正丙醚酸杂质
|
C15H14N2O3S |
302.34826 | |
|
Pitavastatin Impurity 48
|
148516-15-8 |
匹伐他汀杂质34
|
(S,E)-6-(2-(2-cyclopropyl-4-
|
药智官方微信
药智官方微博
